ABT BUE Week ended 24 Jul 2026

Weekly Investor Report

Abbott Laboratories · Healthcare · Medical Devices

Open interactive chart View report data Download investor PDF
Latest close 41,180 ARS
3.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 8.1% above the Trend Line and sits at 46.7% of its 52-week range. The latest completed week returned 3.9%, after a 14.7% four-week move. The latest news-sentiment score is 56/100.

Setup score 51 out of 100
Latest Close 41,180 ARS 24 Jul 2026
1W Return 3.9% latest completed week
4W Return 14.7% short-term follow-through
12W Return 21.2% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Next-week expectancy is positive at 56.98% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.9% Latest completed week; four-week move 14.7%. Indicator stack 26/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.98% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 56/100 30 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 8.1% above the Trend Line and sits at 46.7% of its 52-week range. The latest completed week returned 3.9%, after a 14.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1512-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 14.7% over four weeks, 21.2% over 12 weeks, and 0.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.9%
4W14.7%
12W21.2%
26W1.3%
52W0.7%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.25Latest activity-pressure read.
Pressure change646.2%Four-week change in activity pressure.
Leadership-22.76Latest relative-leadership reading.
RS change28.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 30 relevant articles.

10 positive · 19 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-23.1%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+8.6%Week of 17 Jul.
Worst week-7.9%Week of 8 May.
Latest week+3.9%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses10
Sharp losses4
Recent vol5.1%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryAR Medical Devices
4-week rank1 / 3
Group average7.1%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership

Four-week leaders

ABT · BUE14.7%MDT · BUE6.5%PHG · BUE0.1%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape44/100

Trend, activity pressure, participation, and risk combine to a 44/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.15; No reversal markers Next-Week ExpectancyPositive 56.98%

Next-week expectancy is positive with a 56.98% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 30 relevant articles.

Abbott Laboratories stock gains 2.98 percent amid #WeGiveBlood competition announcement, AbbottNews says Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202641,180 ARS3.9%38,110 ARS35,694 ARS1.25-22.7619.7KOff
17 Jul 202639,640 ARS8.6%38,324 ARS35,529 ARS1.16-24.2329.2KOff
10 Jul 202636,491 ARS-3.2%38,625 ARS35,373 ARS0.72-32.5018.8KOff
3 Jul 202637,682 ARS5.0%38,983 ARS35,233 ARS0.26-29.2828.1KOff
26 Jun 202635,895 ARS7.9%39,307 ARS35,080 ARS-0.23-31.6825.0KOff
19 Jun 202633,273 ARS1.8%39,741 ARS34,939 ARS-0.72-40.46272Off
12 Jun 202632,699 ARS-5.1%40,238 ARS34,815 ARS-0.81-43.121.6KOff
5 Jun 202634,460 ARS8.5%40,766 ARS34,692 ARS-0.87-35.517.9KOff
29 May 202631,760 ARS-2.2%41,162 ARS34,553 ARS-0.96-42.577.2KOff
22 May 202632,480 ARS3.2%41,649 ARS34,432 ARS-0.92-35.2017.7KOff
15 May 202631,460 ARS0.5%42,217 ARS34,307 ARS-1.04-34.3814.8KOff
8 May 202631,300 ARS-7.9%42,830 ARS34,191 ARS-1.05-36.5322.8KOff
1 May 202633,980 ARS-0.4%43,422 ARS34,073 ARS-1.13-33.1515.1KOff
24 Apr 202634,120 ARS-3.6%44,001 ARS33,937 ARS-1.26-33.5118.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.